Close Menu


The agreement covers Japan, Singapore, South Korea, and Taiwan.

The agreement extends a previous deal, under which Tebu-Bio has sold TriLink's modified nucleoside triphosphates and custom oligonucleotides.


The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.